Family Medicine · Hagerstown, MD
NPI
1942281720
Since 2005
Specialty
Family Medicine
Code 207Q00000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
1190 Mount Aetna Rd Ste 202
Hagerstown, MD, 21740
Phone (301) 790-0666
Groups this clinician bills Medicare through
Medicare paid, 2024
$415K
4,494 services
Medicare patients, 2024
885
Average age 80
Drug cost, 2024
$2.4M
31,890 prescriptions
Company payments, 2025
$1,799
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ghazala N Qadir was code 99310 (snf e&m), 1,990 times for 416 patients. In total Ghazala N Qadir billed 4,494 services in 24 codes, and Medicare paid $415K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-08-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99310 SNF E&M | Office | 1,990 | 416 | $109.69 | $218K |
| 99214 Office E&M - Established | Office | 940 | 321 | $79.18 | $74K |
| 99348 Home E&M - New and Established | Office | 601 | 133 | $51.81 | $31K |
| 99306 SNF E&M | Office | 375 | 319 | $133.73 | $50K |
| 99497 Care Management/Coordination | Office | 345 | 302 | $58.65 | $20K |
| 99213 Office E&M - Established | Office | 62 | 57 | $42.09 | $2,610 |
| G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 59 | 59 | $154.33 | $9,106 |
| 99342 Home E&M - New and Established | Office | 44 | 44 | $53.12 | $2,337 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 27 | 27 | $122.86 | $3,317 |
By year: 2022 $245K for 2,856 services; 2023 $314K for 3,287 services; 2024 $415K for 4,494 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 14 | 14 | $2.08 | $29.1 |
Medicare prescription drug claims, 2024
In 2024, the drug Ghazala N Qadir prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,473 prescriptions and refills. In total Ghazala N Qadir wrote 31,890 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,473 | 2,121 | 279 | $21K |
| Levothyroxine Sodium Generic | 1,245 | 1,901 | 231 | $15K |
| Amlodipine Besylate Generic | 1,147 | 1,771 | 213 | $9,359 |
| Gabapentin Generic | 896 | 1,064 | 146 | $13K |
| Lisinopril Generic | 848 | 1,587 | 172 | $6,246 |
| Eliquis Apixaban | 845 | 948 | 121 | $392K |
| Furosemide Generic | 839 | 1,024 | 176 | $5,017 |
| Sertraline Hcl Generic | 768 | 961 | 123 | $7,148 |
| Pantoprazole Sodium Generic | 718 | 1,011 | 158 | $11K |
| Quetiapine Fumarate Generic | 637 | 687 | 81 | $12K |
| Tramadol Hcl Generic | 630 | 632 | 129 | $4,915 |
| Losartan Potassium Generic | 614 | 940 | 122 | $7,021 |
| Omeprazole Generic | 569 | 852 | 110 | $7,302 |
| Metformin Hcl Generic | 547 | 1,068 | 130 | $4,129 |
| Lorazepam Generic | 531 | 531 | 92 | $5,350 |
Brand drugs: 3,911 claims; generic drugs: 27,901 claims; opioid claims: 933.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ghazala N Qadir $1,799 ($1,799 in general payments such as food, travel and fees) from 19 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $215.
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 11 | $215 |
| Abbvie Inc. ABBV | 11 | $212 |
| AstraZeneca Pharmaceuticals LP AZN | 9 | $212 |
| Astellas Pharma US Inc 4503.T | 7 | $192 |
| Novo Nordisk Inc NVO | 7 | $136 |
| Lilly USA, LLC LLY | 5 | $134 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 6 | $116 |
| Teva Pharmaceuticals USA, Inc. TEVA | 6 | $105 |
| Harmony Biosciences LLC HRMY | 3 | $86.33 |
| Exact Sciences Corporation EXAS | 4 | $76.57 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.